Park; Chang H.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Park; Chang H..The latest application filed is for "bromodomain inhibitors".

Company Profile

1.12.17

Park; Chang H. - Wadsworth IL
Park; Chang H - Wadsworth IL
Park; Chang H. - Seoul KR

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Bromodomain Inhibitors App 20190008866 - Bogdan; Andrew ; et al.	2019-01-10
Bromodomain inhibitors Grant 10,085,985 - Bogdan , et al. October 2, 2	2018-10-02
Apoptosis-inducing Agents For The Treatment Of Cancer And Immune And Autoimmune Diseases App 20180251426 - Bruncko; Milan ; et al.	2018-09-06
Isoindolone derivatives Grant 9,776,990 - Pratt , et al. October 3, 2	2017-10-03
Pyridinone and pyridazinone derivatives Grant 9,561,231 - Hubbard , et al. February 7, 2	2017-02-07
Bromodomain Inhibitors App 20160331749 - Bogdan; Andrew ; et al.	2016-11-17
Bromodomain inhibitors Grant 9,428,514 - Bogdan , et al. August 30, 2	2016-08-30
Bcl-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseases Grant 9,125,913 - Bruncko , et al. September 8, 2	2015-09-08
BCL-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseases Grant 9,072,748 - Bruncko , et al. July 7, 2	2015-07-07
Apoptosis-inducing Agents For The Treatment Of Cancer And Immune And Autoimmune Diseases App 20150183775 - BRUNCKO; Milan ; et al.	2015-07-02
Bromodomain Inhibitors App 20150158873 - Bogdan; Andrew ; et al.	2015-06-11
Bcl-2-selective Apoptosis-inducing Agents For The Treatment Of Cancer And Immune Diseases App 20140107119 - Bruncko; Milan ; et al.	2014-04-17
Apoptosis-inducing Agents For The Treatment Of Cancer And Immune And Autoimmune Diseases App 20140088106 - Bruncko; Milan ; et al.	2014-03-27
Apoptosis-inducing Agents For The Treatment Of Cancer And Immune And Autoimmune Diseases App 20140066621 - Bruncko; Milan ; et al.	2014-03-06
Bcl-2-selective Apoptosis-inducing Agents For The Treatment Of Cancer And Immune Diseases App 20140057890 - Bruncko; Milan ; et al.	2014-02-27
Bcl-2-selective Apoptosis-inducing Agents For The Treatment Of Cancer And Immune Diseases App 20140057889 - Bruncko; Milan ; et al.	2014-02-27
Pyridinone and Pyridazinone Derivatives App 20130331382 - HUBBARD; Robert D. ; et al.	2013-12-12
BCL-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseases Grant 8,586,754 - Bruncko , et al. November 19, 2	2013-11-19
Bcl-2 Selective Apoptosis-inducing Agents For The Treatment Of Cancer And Immune Diseases App 20130296295 - BRUNCKO; Milan ; et al.	2013-11-07
Isoindolone Derivatives App 20130281450 - Pratt; John K. ; et al.	2013-10-24
Bcl-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseases Grant 8,563,735 - Bruncko , et al. October 22, 2	2013-10-22
Apoptosis-inducing Agents For The Treatment Of Cancer And Immune And Autoimmune Diseases App 20100298323 - Bruncko; Milan ; et al.	2010-11-25
Bcl-2-selective Apoptosis-inducing Agents For The Treatment Of Cancer And Immune Diseases App 20100298321 - Bruncko; Milan ; et al.	2010-11-25
Apoptosis-inducing Agents For The Treatment Of Cancer And Immune And Autoimmune Diseases App 20100160322 - Bruncko; Milan ; et al.	2010-06-24
Bcl-2-selective Apoptosis-inducing Agents For The Treatment Of Cancer And Immune Diseases App 20100152183 - Bruncko; Milan ; et al.	2010-06-17
Facsimile Grant D369,158 - Park * April 23, 1	1996-04-23
Facsimile Grant D359,485 - Park June 20, 1	1995-06-20

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.